scholarly article | Q13442814 |
P50 | author | Henry F Raymond | Q56961711 |
Scott Geibel | Q46612468 | ||
P2093 | author name string | Andrea A Kim | |
Nicholas Muraguri | |||
Waimar Tun | |||
Helgar Musyoki | |||
Mercy Muthui | |||
Dita Broz | |||
Jerry Okal | |||
Meredith Sheehy | |||
P2860 | cites work | A theme issue by, for, and about Africa: new injecting practice increases HIV risk among drug users in Tanzania | Q24536394 |
The rise of injecting drug use in East Africa: a case study from Kenya | Q24816918 | ||
Estimates of the size of key populations at risk for HIV infection: men who have sex with men, female sex workers and injecting drug users in Nairobi, Kenya | Q26822843 | ||
Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence | Q28249288 | ||
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review | Q28295247 | ||
Global overview of injecting drug use and HIV infection among injecting drug users. | Q31133757 | ||
Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: case study from the WHO Drug Injection Study Phase II | Q33235283 | ||
Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution | Q33245178 | ||
HIV seroprevalence in a sample of Tanzanian intravenous drug users | Q33822369 | ||
Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks | Q34196455 | ||
HIV prevalence and risk behaviours among injecting drug users in six indonesian cities implications for future HIV prevention programs | Q34401872 | ||
Prevention of HIV infection among injection drug users in resource-limited settings | Q35043964 | ||
Correlates of HIV infection among young adult short-term injection drug users. | Q50659913 | ||
Young and recent-onset injecting drug users are at higher risk for HIV. | Q52275816 | ||
The nature of benzodiazepine dependence among heroin users in Sydney, Australia. | Q52279297 | ||
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. | Q55240560 | ||
Respondent-Driven Sampling II: Deriving Valid Population Estimates from Chain-Referral Samples of Hidden Populations | Q56505051 | ||
Respondent-Driven Sampling: A New Approach to the Study of Hidden Populations | Q56505053 | ||
Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV | Q56961744 | ||
Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study | Q35534549 | ||
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. | Q35937711 | ||
Risk factors for human immunodeficiency virus infection in intravenous drug users | Q36154357 | ||
Polydrug abuse: a review of opioid and benzodiazepine combination use | Q36266246 | ||
The role of sexual transmission of HIV infection among injection and non-injection drug users | Q36273534 | ||
HIV treatment as prevention and HPTN 052. | Q36364604 | ||
A systematic review of antiretroviral adherence interventions for HIV-infected people who use drugs | Q36390767 | ||
HIV infection among intravenous drug users: epidemiology and risk reduction. | Q36433344 | ||
Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns | Q36689307 | ||
Migration and transmission of blood-borne infections among injection drug users: understanding the epidemiologic bridge | Q36813560 | ||
Short term estimates of adult HIV incidence by mode of transmission: Kenya and Thailand as examples | Q36958246 | ||
The impact of benzodiazepine use on methadone maintenance treatment outcomes | Q37310406 | ||
Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis | Q37330136 | ||
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage | Q37699887 | ||
Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria | Q37846011 | ||
High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey | Q38489016 | ||
A rapid assessment of heroin use in Mombasa, Kenya | Q38899297 | ||
HIV/AIDS and injection drug use in the neighborhoods of Dar es Salaam, Tanzania | Q39758546 | ||
Prevalence and incidence of hepatitis C virus infection among young adult injection drug users | Q42680870 | ||
Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial. | Q42937874 | ||
Hepatitis C virus seroconversion among young injection drug users: relationships and risks | Q43041146 | ||
Highly active antiretroviral therapy and survival in HIV-infected injection drug users. | Q43903854 | ||
Harm reduction in Tanzania: an urgent need for multisectoral intervention | Q43945524 | ||
Differences in HIV risk behaviors by gender in a sample of Tanzanian injection drug users | Q43946479 | ||
Heroin and HIV risk in Dar es Salaam, Tanzania: youth hangouts, mageto and injecting practices. | Q43947715 | ||
The importance of preventing hepatitis C virus infection among injection drug users in the United States. | Q44458986 | ||
HIV prevention among drug users: outcome of a network-oriented peer outreach intervention | Q44562867 | ||
A profile on HIV prevalence and risk behaviors among injecting drug users in Nigeria: should we be alarmed? | Q44676228 | ||
Commercial sex work and risk of HIV infection among young drug-injecting men who have sex with men in San Francisco. | Q46399768 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P304 | page(s) | S24-35 | |
P577 | publication date | 2015-02-01 | |
P1433 | published in | AIDS and Behavior | Q15752229 |
P1476 | title | HIV and STI prevalence and injection behaviors among people who inject drugs in Nairobi: results from a 2011 bio-behavioral study using respondent-driven sampling | |
P478 | volume | 19 Suppl 1 |
Q55346664 | "Who has ever loved a drug addict? It's a lie. They think a 'teja' is as bad person": multiple stigmas faced by women who inject drugs in coastal Kenya. |
Q39036224 | Access to HIV treatment and care for people who inject drugs in Kenya: a short report |
Q36837365 | An ethnographic exploration of drug markets in Kisumu, Kenya |
Q47723455 | Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: role of community-based outreach and drop-in centers |
Q57297558 | Biometrics and public health surveillance in criminalised and key populations: policy, ethics, and human rights considerations |
Q59336673 | Can HIV service data be used for surveillance purposes?: a case study in Guangzhou, China |
Q37352481 | Commentary: the value of PrEP for people who inject drugs |
Q64887689 | Depression, injecting drug use, and risky sexual behavior syndemic among women who inject drugs in Kenya: a cross-sectional survey. |
Q64903561 | Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs. |
Q61798801 | HIV risk behaviours among women who inject drugs in coastal Kenya: findings from secondary analysis of qualitative data |
Q93083224 | HIV- and hepatitis C-related risk behaviors among people who inject drugs in Uganda: implications for policy and programming |
Q91611055 | High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique |
Q53688262 | Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. |
Q91789329 | Integrated and differentiated methadone and HIV care for people who use drugs: a qualitative study in Kenya with implications for implementation science |
Q35954772 | Lessons learned from respondent-driven sampling recruitment in Nairobi: experiences from the field |
Q90431738 | Prevalence and determinants of unprotected sex in intimate partnerships of men who inject drugs: findings from a prospective intervention study |
Q48148463 | Socio-demographic and sexual practices associated with HIV infection in Kenyan injection and non-injection drug users |